This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

By Otto V. St. Whitelock, Editor in Chief; Franklin N. Furness, Managing Editor; Philip Ressner, Associate Editor, and Martin G. Goldner, Consulting Editor. Price, not given. Pp. 1028, with many illustrations. N.Y. Acad. of Science, 2E. 63rd St., New York 21, 1959.

Robert C. Hardin, M.D., Reviewer

AMA Arch Intern Med. 1959;104(5):840-841.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This volume arises from the conference on Chlorpropamide and Diabetes Mellitus, supported jointly by the New York Academy of Sciences and Charles Pfizer and Company, held in New York in September, 1958. It is a collection of sixty-eight articles written by more than one hundred seventy authors and defies condensation in a review of usual length and substance. Dr. Charles H. Best has accomplished this as well as it can be done in a six-page summary at the end of the book.

The contributions are arranged in three groups. The first is concerned with pharmacological studies, the second with metabolic research, and the third with clinical observations. The subject matter is not confined wholly to the consideration of chlorpropamide but includes other sulfonylurea compounds and, as is proper, related data about insulin. This is particularly true of the first two sections.

This publication is, of course, valuable for the investigator . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?